Chronic ethanol treatment of human hepatocytes inhibits the activation of the insulin signaling pathway by increasing cytosolic free calcium levels

Chen,Yi‑Min; Zhao,Jin‑Fang; Liu,Yong‑Lin; Chen,Jie; Jiang,Rong‑Lin

doi:10.3892/ijmm.2015.2282

Chronic ethanol treatment of human hepatocytes inhibits the activation of the insulin signaling pathway by increasing cytosolic free calcium levels

Authors:
- Yi‑Min Chen
- Jin‑Fang Zhao
- Yong‑Lin Liu
- Jie Chen
- Rong‑Lin Jiang
View Affiliations

Affiliations: Department of Clinical Laboratory, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China, Department of Endocrinology, The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China, Department of Intensive Care Unit, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China
Published online on: July 13, 2015 https://doi.org/10.3892/ijmm.2015.2282
Pages: 739-746

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effects of ethanol treatment on the induction of intracellular calcium ([Ca2+]i) levels and the inhibition of the activation of the insulin signaling pathway in human hepatocytes. L‑02 cells were treated with various concentrations of ethanol for different periods of time. Cell viability and alanine aminotransferase (ALT)/aspartate aminotransferase (AST) leakage in the culture supernatant were evaluated. Changes in [Ca2+]i levels were detected by flow cytometry and confocal microscopy. Total RNA and protein were extracted to examine the mRNA and protein levels of insulin receptor substrate (IRS)1, IRS2, phosphatidylinositol 3‑kinase (PI3K) and glucose transporter 2 (GLUT2) by reverse transcription-quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis, respectively. Furthermore, insulin was added to the ethanol‑treated L‑02 cells, and the phosphorylation levels of PI3K and protein kinase B (PKB) were determined by western blot analysis before and after Ca2+ blockage. No significant changes were observed in cell viability, [Ca2+]i levels and in the expression and phosphorylation levels of insulin signal transduction molecules when the L‑02 cells were treated with 0.5 or 1% ethanol. However, treatment with 2 or 4% ethanol resulted in a significant decrease in cell viability and in the mRNA levels of IRS1, IRS2, PI3K (p85α) and GLUT2, as well as in an increase in ALT/AST leakage and in the [Ca2+]i levels (P<0.05). The expression and phosphorylation levels of PI3K (p85α) and PKB were also inhibited by treatment with 2 or 4% ethanol. These cytological effects induced by ethanol treatment were partially reversed by Ca2+ blockage. These results suggest that ethanol treatment inhibits the activation of the insulin signal transduction pathway in a dose‑, time‑ and Ca2+‑dependent manner. The inhibition of IRS1/2, PI3K (p85α), PKB and GLUT2 expression and of PI3K (p85α) and PKB phosphorylation by the high concentrations of ethanol may be the core molecular mechanism of ethanol-induced insulin resistance, and may be related to the induction of [Ca2+]i levels.

View Figures

View References

1	Wannamethee SG, Shaper AG, Perry IJ and Alberti KG: Alcohol consumption and the incidence of type II diabetes. J Epidemiol Community Health. 56:542–548. 2002. View Article : Google Scholar : PubMed/NCBI
2	Pietraszek A, Gregersen S and Hermansen K: Alcohol and type 2 diabetes. A review. Nutr Metab Cardiovasc Dis. 20:366–375. 2010. View Article : Google Scholar : PubMed/NCBI
3	Cullmann M, Hilding A and Östenson CG: Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population. Diabet Med. 29:441–452. 2012. View Article : Google Scholar
4	Fan AZ, Russell M, Naimi T, Li Y, Liao Y, Jiles R and Mokdad AH: Patterns of alcohol consumption and the metabolic syndrome. J Clin Endocrinol Metab. 93:3833–3838. 2008. View Article : Google Scholar : PubMed/NCBI
5	Petersen KF and Shulman GI: Etiology of insulin resistance. Am J Med. 119(Suppl 1): S10–S16. 2006. View Article : Google Scholar : PubMed/NCBI
6	Ismail-Beigi F: Pathogenesis and glycemic management of type 2 diabetes mellitus: a physiological approach. Arch Iran Med. 15:239–246. 2012.PubMed/NCBI
7	Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M and Canbay A: The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 56:952–964. 2012. View Article : Google Scholar
8	Saltiel AR and Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 414:799–806. 2001. View Article : Google Scholar : PubMed/NCBI
9	Liu H, Jia X, Luo Z, Guan H, Jiang H, Li X and Yan M: Inhibition of store-operated Ca²⁺ channels prevent ethanol-induced intracellular Ca²⁺ increase and cell injury in a human hepatoma cell line. Toxicol Lett. 208:254–261. 2012. View Article : Google Scholar
10	Vagts AJ, He DY, Yaka R and Ron D: Cellular adaptation to chronic ethanol results in altered compartmentalization and function of the scaffolding protein RACK1. Alcohol Clin Exp Res. 27:1599–1605. 2003. View Article : Google Scholar : PubMed/NCBI
11	Shih CL, Chi SI, Chiu TH, Sun GY and Lin TN: Ethanol effects on nitric oxide production in cerebral pial cultures. Alcohol Clin Exp Res. 25:612–618. 2001. View Article : Google Scholar : PubMed/NCBI
12	Kim E, Seok HH, Lee SY, Lee DR, Moon J, Yoon TK, Lee WS and Lee KA: Correlation between expression of glucose transporters in granulosa cells and oocyte quality in women with polycystic ovary syndrome. Endocrinol Metab (Seoul). 29:40–47. 2014. View Article : Google Scholar
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
14	Thiele TE: Insulin resistance from binge drinking: It's all in your head. Sci Transl Med. 5:170fs32013. View Article : Google Scholar : PubMed/NCBI
15	Tang YL, Xiang XJ, Wang XY, Cubells JF, Babor TF and Hao W: Alcohol and alcohol-related harm in China: policy changes needed. Bull World Health Organ. 91:270–276. 2013. View Article : Google Scholar : PubMed/NCBI
16	Carlsson S, Hammar N, Grill V and Kaprio J: Alcohol consumption and the incidence of type 2 diabetes: a 20-year follow-up of the Finnish twin cohort study. Diabetes Care. 26:2785–2790. 2003. View Article : Google Scholar : PubMed/NCBI
17	Lee K: Gender-specific relationships between alcohol drinking patterns and metabolic syndrome: the Korea National Health and Nutrition Examination Survey 2008. Public Health Nutr. 15:1917–1924. 2012. View Article : Google Scholar : PubMed/NCBI
18	Onishi Y, Honda M, Ogihara T, Sakoda H, Anai M, Fujishiro M, Ono H, Shojima N, Fukushima Y, Inukai K, et al: Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation. Biochem Biophys Res Commun. 303:788–794. 2003. View Article : Google Scholar : PubMed/NCBI
19	Wilkes JJ, DeForrest LL and Nagy LE: Chronic ethanol feeding in a high-fat diet decreases insulin-stimulated glucose transport in rat adipocytes. Am J Physiol. 271:E477–E484. 1996.PubMed/NCBI
20	Xu D, Dhillon AS, Davey CG, Fournier PA and Palmer TN: Alcohol and glucose metabolism in skeletal muscles in the rat. Addict Biol. 1:71–83. 1996. View Article : Google Scholar : PubMed/NCBI
21	Guo S: Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol. 220:T1–T23. 2014. View Article : Google Scholar
22	White MF: Insulin signaling in health and disease. Science. 302:1710–1711. 2003. View Article : Google Scholar : PubMed/NCBI
23	Kadowaki T: Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest. 106:459–465. 2000. View Article : Google Scholar : PubMed/NCBI
24	Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, et al: Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900–904. 1998. View Article : Google Scholar : PubMed/NCBI
25	Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF and Accili D: Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest. 105:199–205. 2000. View Article : Google Scholar : PubMed/NCBI
26	Benito M: Tissue specificity on insulin action and resistance: past to recent mechanisms. Acta Physiol (Oxf). 201:297–312. 2011. View Article : Google Scholar
27	Pagliassotti MJ, Kang J, Thresher JS, Sung CK and Bizeau ME: Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance. Am J Physiol Endocrinol Metab. 282:E170–E176. 2002.
28	Nevado C, Valverde AM and Benito M: Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. Endocrinology. 147:3709–3718. 2006. View Article : Google Scholar : PubMed/NCBI
29	Karim S, Adams DH and Lalor PF: Hepatic expression and cellular distribution of the glucose transporter family. World J Gastroenterol. 18:6771–6781. 2012. View Article : Google Scholar : PubMed/NCBI
30	Cui RB, Kan BT, Sun XM, Luo Z, Guo R, Guo XL and Yan M: Role of store-operated Ca²⁺ channels in primary hepatocytes under conditions of calcium overload and ethanol-induced injury. Zhonghua Gan Zang Bing Za Zhi. 21:860–864. 2013.In Chinese. PubMed/NCBI
31	Caro AA and Cederbaum AI: Role of calcium and calcium-activated proteases in CYP2E1-dependent toxicity in HEPG2 cells. J Biol Chem. 277:104–113. 2002. View Article : Google Scholar